13-37636971-T-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_016179.4(TRPC4):āc.2866A>Gā(p.Ser956Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000477 in 1,613,620 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_016179.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TRPC4 | NM_016179.4 | c.2866A>G | p.Ser956Gly | missense_variant | 11/11 | ENST00000379705.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TRPC4 | ENST00000379705.8 | c.2866A>G | p.Ser956Gly | missense_variant | 11/11 | 1 | NM_016179.4 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152152Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000637 AC: 16AN: 251096Hom.: 0 AF XY: 0.0000663 AC XY: 9AN XY: 135720
GnomAD4 exome AF: 0.0000431 AC: 63AN: 1461468Hom.: 0 Cov.: 31 AF XY: 0.0000481 AC XY: 35AN XY: 727046
GnomAD4 genome AF: 0.0000920 AC: 14AN: 152152Hom.: 0 Cov.: 32 AF XY: 0.0000942 AC XY: 7AN XY: 74338
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 06, 2023 | The c.2881A>G (p.S961G) alteration is located in exon 11 (coding exon 10) of the TRPC4 gene. This alteration results from a A to G substitution at nucleotide position 2881, causing the serine (S) at amino acid position 961 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at